SEC Form 4 · accession 0001144204-15-017760

Esperion Therapeutics, Inc. · ESPR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Patrick G Enright

Director

Period of report

Mar 19, 2015

Accepted (ET)

Mar 23, 2015 · 4:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001434868

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F11	Mar 19, 2015	S	283,601	$110.0069	D	1,122,609	I	By LVP
Common Stock^F2,F11	Mar 19, 2015	S	3,353	$111.059	D	1,119,256	I	By LVP
Common Stock^F3,F11	Mar 19, 2015	S	194,988	$113.9183	D	924,268	I	By LVP
Common Stock^F4,F11	Mar 19, 2015	S	2,156	$114.1453	D	922,112	I	By LVP
Common Stock^F5,F11	Mar 19, 2015	S	6,077	$116.053	D	916,035	I	By LVP
Common Stock^F6,F11	Mar 19, 2015	S	5,684	$110.0069	D	22,502	I	By LCA
Common Stock^F7,F11	Mar 19, 2015	S	67	$111.0594	D	22,435	I	By LCA
Common Stock^F8,F11	Mar 19, 2015	S	3,907	$113.9185	D	18,528	I	By LCA
Common Stock^F9,F11	Mar 19, 2015	S	44	$114.1453	D	18,484	I	By LCA
Common Stock^F10,F11	Mar 19, 2015	S	123	$116.053	D	18,361	I	By LCA

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $110.00 to $110.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F10Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $115.405 to $116.305. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F11Mr. Enright is a managing member of Longitude Capital Partners, LLC ("Longitude Capital"). Longitude Capital, as the general partner of each of Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA"), has the power to vote and dispose of securities held by each of them. As such, Mr. Enright may be deemed to beneficially own the shares held by LVP and LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of his pecuniary interest therein.
F2Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $111.00 to $111.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F3Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $113.03 to $114.01. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $114.03 to $114.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $115.405 to $116.305. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F6Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $110.00 to $110.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F7Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $111.00 to $111.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F8Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $113.03 to $114.01. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F9Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $114.03 to $114.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.